Rule 425 Communication · 425
Endo LP
Rule 425 Communication
Company context
Endo is a diversified pharmaceutical company boldly transforming insights into life-enhancing therapies. Our passionate team members collaborate to develop and deliver these essential medicines. Together, we are committed to helping everyone we serve live their best life. Learn more at www.endo.com or connect with us on LinkedIn.
Recent company filings
- 15-15D filingAug 5, 2025
- EFFECT filingAug 4, 2025
- S-8 POS filingAug 1, 2025
- POS AM filingAug 1, 2025
- Completion of Acquisition or Disposition of Assets · Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing · Material Modification to Rights of Security Holders · Changes in Control of Registrant · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearAug 1, 2025
As-filed source
As filedOpen full document ↗